Inhibition of miR-155 Attenuates CD14+ Monocyte-Mediated Inflammatory Response and Oxidative Stress in Psoriasis Through TLR4/MyD88/NF-κB Signaling Pathway
Authors:
Open Access
- 1 February 2022
- journal article
- research article
- Published by Taylor & Francis in Clinical, Cosmetic and Investigational Dermatology
- Vol. ume 15, 193-201
Abstract
Purpose: Previous studies showed the link of CD14+ monocytes to inflammation and oxidation in psoriasis. In the present study, we investigated the regulatory role of miR-155 in CD14+ monocyte function in psoriasis. Materials and Methods: CD14+ monocytes were isolated from peripheral blood by magnetic bead separation method and its function was assessed following silence of miR-155 by lentivirus transfection with or without inhibition of TLR4 pathway. CCK8 and EdU were used to assess the proliferation of CD14+ monocytes. Expression levels of SOCS1, TLR4 and MyD88 proteins were determined by Western blotting, while expression levels of IL-6, TNF-α, ROS, MDA and T-AOC were measured by ELISA kit. The expression levels of mRNA for miR-155, NF-κB and its subunit NF-κB-p65 were assessed by q-PCR. Results: The results showed that compared with normal control CD14+ monocytes, the expression levels of miR-155, NF-κB and NF-κB-p65, TLR4, MyD88 and IL-6, TNF-α were increased, while expression levels of SOCS1 were decreased in CD14+ monocytes from psoriatic patients. Enhanced cell proliferation and oxidation were also observed in CD14+ monocytes from psoriatic patients. Inhibition of miR-155 partially corrected the abnormalities of cell proliferation and expression levels of biomarkers mentioned above in CD14+ monocytes from psoriatic patients. Inhibitions of both TLR4 pathway and miR-155 further corrected abnormalities of proliferation and the above biomarkers in CD14+ monocytes from psoriatic patients. Conclusion: These results suggest that increased expression levels of miR-155 contribute to CD14+ monocyte-mediated inflammation and oxidation in psoriasis via TLR4 pathway.Keywords
This publication has 36 references indexed in Scilit:
- miR‐155 as a multiple sclerosis–relevant regulator of myeloid cell polarizationAnnals of Neurology, 2013
- The history of Toll-like receptors — redefining innate immunityNature Reviews Immunology, 2013
- Molecular characterisation of porcine miR-155 and its regulatory roles in the TLR3/TLR4 pathwaysDevelopmental & Comparative Immunology, 2013
- Increased microRNA-155 expression in the serum and peripheral monocytes in chronic HCV infectionJournal of Translational Medicine, 2012
- Repressed induction of interferon‐related microRNAs miR‐146a and miR‐155 in peripheral blood mononuclear cells infected with HCV genotype 4FEBS Open Bio, 2012
- miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cellsBlood, 2010
- CD16 (FcRγIII) as a potential marker of osteoclast precursors in psoriatic arthritisArthritis Research & Therapy, 2010
- Effects of vitamin D on expression of Toll-like receptors of monocytes from patients with Behcet's diseaseRheumatology, 2008
- Toll-like receptor signallingNature Reviews Immunology, 2004
- Nuclear transcription factor-κB as a target for cancer drug developmentLeukemia, 2002